GoCheck
Venture Round in 2021
GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.
PMV Pharmaceuticals
Series C in 2019
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.
Welcome
Venture Round in 2019
Welcome is a marketing orchestration platform, designed to streamline and optimize marketing operations for large, ambitious brands. It aligns marketing teams, simplifies campaign execution, and provides measurable results. Welcome integrates with other marketing technology tools, enabling better collaboration and performance tracking. It serves as a central hub for marketing teams, supporting their growth and enhancing overall marketing performance.
Aryaka Networks
Series F in 2019
Aryaka Networks designs and delivers cloud-based network connectivity and application acceleration solutions for enterprises worldwide. Its unified Secure Access Service Edge (SASE) platform combines networking and security functions, optimizing global Wide Area Network performance and enhancing security in over 100 countries.
GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.
Splice Machine
Venture Round in 2019
Splice Machine is a data platform company offering a hybrid, open-source dual-engine relational database and a unified data layer that combines streaming, analytics and transactions. The platform supports mixed operational and analytical workloads, running operational tasks on one engine with Hadoop and HBase and analytical tasks on Spark, enabling real-time updates for applications and batch analysis for insights. It helps replace traditional databases by reducing latency and cost and supports the development of real-time, scalable applications. With built-in machine learning support, the platform accelerates offloading workloads and integrates analytics and AI into mission-critical applications across IoT, ETL, operational reporting and other data-driven workflows. The company is based in San Francisco.
Aria Systems
Private Equity Round in 2018
Aria Systems provides a cloud-based platform for managing recurring revenues. It offers Aria, an enterprise-grade solution for subscription-based billing, serving clients across hi-tech, media, telecom, and finance industries worldwide.
The RealReal
Series G in 2018
The RealReal operates an online marketplace for authenticated luxury resale, offering fashion for women, men and kids, as well as jewelry, watches, art and home items. Founded in 2011 and headquartered in San Francisco, it functions as a full-service consignment platform that authenticates every item through in-house experts and uses technology to determine pricing, while managing photography, listings, payments and shipping. It is the largest pure-play luxury resale platform in the United States and supports a sustainable circular economy by facilitating resale across multiple categories. The company generates revenue primarily from consignments and first-party sales on its marketplace, with additional direct sales, and provides services such as virtual appointments, in-home pickup and direct shipping to buyers.
Aryaka Networks
Series E in 2018
Aryaka Networks designs and delivers cloud-based network connectivity and application acceleration solutions for enterprises worldwide. Its unified Secure Access Service Edge (SASE) platform combines networking and security functions, optimizing global Wide Area Network performance and enhancing security in over 100 countries.
Avedro, Inc. is a commercial-stage ophthalmic pharmaceutical and medical device company headquartered in Waltham, Massachusetts. The company specializes in developing and commercializing innovative products for treating corneal disorders, primarily focusing on corneal ectatic conditions and refractive issues. Avedro's proprietary Corneal Remodeling Platform includes the KXL and Mosaic systems, which utilize ultraviolet A (UVA) light in conjunction with riboflavin drug formulations for corneal cross-linking. This technology is aimed at strengthening and reshaping the cornea through minimally invasive and non-invasive outpatient procedures. Avedro has also introduced the Keraflex refractive correction procedure, a non-invasive technique for flattening the cornea without tissue removal. While Avedro primarily serves ophthalmologists, hospitals, and ambulatory surgery centers in the United States, it also markets its products internationally through medical device distributors. The company, originally named ThermalVision, Inc., was incorporated in 2002 and rebranded as Avedro in 2005. As of November 2019, Avedro operates as a subsidiary of Glaukos Corporation.
Totango develops a customer success platform that helps businesses drive customer adoption, retention, expansion, and referrals. Its solutions include automated workflows, engagement features, and AI-powered predictive analytics to monitor customer health and proactively reduce churn. Totango serves leading customer success teams worldwide, including SAP and GitHub.
Gynesonics
Private Equity Round in 2018
Gynesonics, Inc. is a medical device company focused on developing innovative solutions for women's health, specifically addressing symptomatic uterine fibroids. Founded in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, Gynesonics offers the Sonata System, a minimally invasive treatment that utilizes sonography guidance for the transcervical ablation of fibroids. This incision-free approach provides a safe and effective alternative to traditional surgical methods such as hysterectomy or myomectomy, aiming to alleviate severe menstrual symptoms associated with fibroids. Gynesonics is dedicated to improving the quality of care for women by offering advanced technologies that enhance treatment options in gynecology.
Centrexion Therapeutics
Series D in 2018
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company based in Boston, Massachusetts, dedicated to developing novel, non-opioid, and non-addictive therapies for chronic pain management. Founded in 2013, the company focuses on addressing significant unmet medical needs in this area. Its product pipeline includes CNTX-4975, currently in Phase III trials for moderate to severe knee osteoarthritis pain, as well as Phase II trials for Mortonâs neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials targeting chronic pain linked to inflammatory and neuropathic conditions. Other candidates include CNTX-6970, also in Phase I for inflammatory pain, and CNTX-2022, a high-concentration topical lidocaine gel in Phase I for various pain types. CNTX-6016 is in pre-clinical stages for chronic neuropathic pain. Centrexion aims to provide patients with safe and effective pain relief options through innovative treatment modalities.
Splice Machine
Series B in 2017
Splice Machine is a data platform company offering a hybrid, open-source dual-engine relational database and a unified data layer that combines streaming, analytics and transactions. The platform supports mixed operational and analytical workloads, running operational tasks on one engine with Hadoop and HBase and analytical tasks on Spark, enabling real-time updates for applications and batch analysis for insights. It helps replace traditional databases by reducing latency and cost and supports the development of real-time, scalable applications. With built-in machine learning support, the platform accelerates offloading workloads and integrates analytics and AI into mission-critical applications across IoT, ETL, operational reporting and other data-driven workflows. The company is based in San Francisco.
Achates Power
Series D in 2017
Founded in 2004, Achates Power specializes in developing, manufacturing, and marketing advanced internal combustion engines for commercial truck manufacturers, passenger vehicle producers, military, maritime, and stationary power industries worldwide. Its primary offerings include opposed-piston, two-stroke, and compression ignition engines, along with engineering services and technology licenses.
Braze is a customer engagement platform that helps brands deliver relevant, human experiences across channels. It offers a mobile marketing automation and customer relationship management solution with AI-powered tools for engagement orchestration, including messaging, chatbots, and content management, plus campaign optimization insights, data analysis, and segment analytics. The platform enables cross-channel personalization across mobile, email, web, television, and connected devices, and provides data security, data warehousing and streaming capabilities. Braze uses AI to power functionality across its stack. Founded in 2011 and headquartered in New York, it has offices in London, San Francisco, Chicago, and Singapore. Braze serves industries such as retail and e-commerce, media and entertainment, financial services, and travel and hospitality, focusing on timely, contextually relevant interactions between consumers and brands.
Aria Systems
Series F in 2017
Aria Systems provides a cloud-based platform for managing recurring revenues. It offers Aria, an enterprise-grade solution for subscription-based billing, serving clients across hi-tech, media, telecom, and finance industries worldwide.
Neuronetics
Series G in 2017
Neuronetics is a medical technology company that designs, develops, and markets non-invasive therapies for psychiatric disorders. Its flagship product, NeuroStar Advanced Therapy System, uses transcranial magnetic stimulation to treat adult patients with major depressive disorder in office-based settings.
Avedro
Venture Round in 2017
Avedro, Inc. is a commercial-stage ophthalmic pharmaceutical and medical device company headquartered in Waltham, Massachusetts. The company specializes in developing and commercializing innovative products for treating corneal disorders, primarily focusing on corneal ectatic conditions and refractive issues. Avedro's proprietary Corneal Remodeling Platform includes the KXL and Mosaic systems, which utilize ultraviolet A (UVA) light in conjunction with riboflavin drug formulations for corneal cross-linking. This technology is aimed at strengthening and reshaping the cornea through minimally invasive and non-invasive outpatient procedures. Avedro has also introduced the Keraflex refractive correction procedure, a non-invasive technique for flattening the cornea without tissue removal. While Avedro primarily serves ophthalmologists, hospitals, and ambulatory surgery centers in the United States, it also markets its products internationally through medical device distributors. The company, originally named ThermalVision, Inc., was incorporated in 2002 and rebranded as Avedro in 2005. As of November 2019, Avedro operates as a subsidiary of Glaukos Corporation.
PMV Pharmaceuticals
Series B in 2017
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.
Vidora, Inc. is a technology company based in San Francisco, California, that specializes in developing a real-time machine learning platform called Cortex. Founded in 2012, Vidora aims to enhance the performance of marketing and product teams by providing a no-code solution for machine learning. The Cortex platform enables organizations to make predictions that optimize conversions and engagement through end-to-end automation, allowing businesses to create numerous predictions without the associated risks and costs of in-house development. Major global brands, such as Walmart and News Corp, utilize Vidora's technology to analyze continuous streams of raw data, ultimately personalizing customer experiences across various content and marketing channels. Additionally, Vidora has established a strategic partnership with MoEngage to further enhance its offerings.
Centrexion Therapeutics
Series C in 2016
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company based in Boston, Massachusetts, dedicated to developing novel, non-opioid, and non-addictive therapies for chronic pain management. Founded in 2013, the company focuses on addressing significant unmet medical needs in this area. Its product pipeline includes CNTX-4975, currently in Phase III trials for moderate to severe knee osteoarthritis pain, as well as Phase II trials for Mortonâs neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials targeting chronic pain linked to inflammatory and neuropathic conditions. Other candidates include CNTX-6970, also in Phase I for inflammatory pain, and CNTX-2022, a high-concentration topical lidocaine gel in Phase I for various pain types. CNTX-6016 is in pre-clinical stages for chronic neuropathic pain. Centrexion aims to provide patients with safe and effective pain relief options through innovative treatment modalities.
Integrated Diagnostics
Series C in 2016
Integrated Diagnostics Inc. is a company focused on developing laboratory-based blood diagnostic tools that facilitate the early diagnosis of complex diseases through non-invasive blood tests. Established in 2005 and headquartered in Seattle, Washington, the company specializes in products that monitor multiple molecular markers simultaneously, offering valuable insights for conditions such as lung cancer. One of its key offerings is Xpresys Lung, a molecular blood test designed to provide objective information for assessing pulmonary nodules. Integrated Diagnostics is committed to leveraging advanced technologies to create a pipeline of innovative diagnostic products aimed at enhancing disease management for conditions including cancer, diabetes, and Alzheimer's. The company operates under a strategic partnership with Agilent Technologies Inc. and has been functioning as a subsidiary of Biodesix, Inc. since 2018.
Grokker operates an online fitness platform offering thousands of expert-led videos covering various cooking styles, yoga practices, and workout routines. Its holistic wellness program caters to employees worldwide, promoting physical health through personalized video content and community support.
ReVision Optics
Venture Round in 2016
ReVision Optics, Inc. is a company that specializes in designing, manufacturing, and delivering implantable products aimed at treating presbyopia, a condition associated with the natural aging process that affects near vision. The company's flagship product, the PRESBYLENS Corneal Inlay, offers a patented refractive surgery solution that enhances visual acuity for individuals experiencing age-related vision loss. Founded in 1996 and based in Lake Forest, California, ReVision Optics serves ophthalmology professionals, providing them with advanced technology to improve patient outcomes. Originally established as IntraLens Vision, Inc., the company rebranded to its current name in 2005, reflecting its focus on innovative optical solutions.
Cheetah Digital
Series A in 2016
Cheetah Digital is a provider of cross-channel customer engagement solutions tailored for modern marketers. The company offers a Customer Engagement Suite that empowers enterprise brands to enhance revenue, foster enduring customer relationships, and facilitate unique value exchanges throughout the customer lifecycle. Cheetah Digital's platform allows marketers to create personalized experiences, implement cross-channel messaging, and develop loyalty strategies, all supported by an engagement data platform designed to adapt to the evolving needs of today's consumers. By focusing on marketers rather than IT-centric approaches, Cheetah Digital positions itself as a leader in delivering effective marketing solutions.
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltokâs solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.
Totango develops a customer success platform that helps businesses drive customer adoption, retention, expansion, and referrals. Its solutions include automated workflows, engagement features, and AI-powered predictive analytics to monitor customer health and proactively reduce churn. Totango serves leading customer success teams worldwide, including SAP and GitHub.
Stellar Loyalty
Venture Round in 2016
Stellar Loyalty Inc. is a provider of cloud-based customer loyalty and engagement solutions founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines. The company specializes in mobile and big data solutions that enable brands to connect their loyalty programs with point-of-sale, marketing, and customer relationship management systems. This integration allows businesses to recognize, engage, and reward their customers effectively. Stellar Loyalty's platform offers functionalities in calculations, business rules, segmentations, and predictive analytics, aimed at enhancing consumer experiences across various interaction channels, including digital, physical, and human touchpoints.
C3.ai, Inc. is an enterprise artificial intelligence software company specializing in software-as-a-service applications aimed at accelerating digital transformation for businesses. The company offers the C3 AI Suite, an end-to-end platform that facilitates the design, development, and deployment of AI applications across various industries. Its portfolio includes industry-specific solutions such as inventory optimization, supply network risk assessment, customer churn management, production schedule optimization, predictive maintenance, and fraud detection. C3.ai serves a wide range of sectors, including oil and gas, manufacturing, financial services, healthcare, and telecommunications. Additionally, the company has formed strategic partnerships with major firms like Baker Hughes, FIS, Raytheon, Microsoft, and Adobe to enhance its offerings. Founded in 2009 and headquartered in Redwood City, California, C3.ai continues to innovate in the field of artificial intelligence, providing tools that significantly improve operational efficiency and decision-making for enterprises.
Restoration Robotics
Venture Round in 2016
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. It has developed the ARTAS⢠System, an innovative image-guided platform that facilitates follicular unit extraction, enhancing the precision and efficiency of hair restoration procedures. By integrating advanced imaging and robotics, Restoration Robotics aims to improve outcomes for patients seeking hair transplants, positioning itself as a leader in the evolving field of hair restoration. The company is committed to transforming traditional practices through its state-of-the-art technology.
GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.
Wiser Solutions
Venture Round in 2016
Wiser Solutions is a leading provider of actionable data aimed at enhancing decision-making for brands and retailers. The company specializes in collecting and analyzing both online and in-store data with notable speed and precision. Its platform integrates insights from the retail sector with advanced workflow software, creating a comprehensive solution that serves various retail needs, including those of restaurants. By combining data science with human validation, Wiser offers a centralized approach to retail data analysis, enabling businesses to drive revenue, reduce costs, and improve marketing efficiency.
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.
Braze is a customer engagement platform that helps brands deliver relevant, human experiences across channels. It offers a mobile marketing automation and customer relationship management solution with AI-powered tools for engagement orchestration, including messaging, chatbots, and content management, plus campaign optimization insights, data analysis, and segment analytics. The platform enables cross-channel personalization across mobile, email, web, television, and connected devices, and provides data security, data warehousing and streaming capabilities. Braze uses AI to power functionality across its stack. Founded in 2011 and headquartered in New York, it has offices in London, San Francisco, Chicago, and Singapore. Braze serves industries such as retail and e-commerce, media and entertainment, financial services, and travel and hospitality, focusing on timely, contextually relevant interactions between consumers and brands.
Obalon Therapeutics
Series E in 2016
Obalon Therapeutics, Inc. is a medical device company based in Carlsbad, California, that specializes in developing and commercializing innovative solutions for obesity treatment. The company's flagship product, the Obalon Balloon System, is designed to assist weight loss in obese patients through a swallowable capsule that contains an inflatable balloon. This system includes the Obalon Navigation System, which utilizes hardware and software to monitor the balloon's placement, as well as the Obalon Touch Inflation Dispenser, a semi-automated device for inflating the balloon post-placement. Founded in 2008, Obalon emphasizes engineering excellence and close collaboration with clinicians to create high-quality medical products aimed at improving patient outcomes. As of early 2020, the company operated three retail treatment centers in California, underscoring its commitment to providing accessible weight loss solutions.
The RealReal
Series E in 2016
The RealReal operates an online marketplace for authenticated luxury resale, offering fashion for women, men and kids, as well as jewelry, watches, art and home items. Founded in 2011 and headquartered in San Francisco, it functions as a full-service consignment platform that authenticates every item through in-house experts and uses technology to determine pricing, while managing photography, listings, payments and shipping. It is the largest pure-play luxury resale platform in the United States and supports a sustainable circular economy by facilitating resale across multiple categories. The company generates revenue primarily from consignments and first-party sales on its marketplace, with additional direct sales, and provides services such as virtual appointments, in-home pickup and direct shipping to buyers.
Eiger BioPharmaceuticals
Debt Financing in 2016
Eiger BioPharmaceuticals is a late-stage biopharmaceutical company headquartered in Palo Alto, California, specializing in the development of targeted therapies for rare and ultra-rare diseases. The company's lead product candidate, Lonafarnib, is an orally bioavailable small molecule currently in Phase 3 clinical trials for the treatment of hepatitis delta virus (HDV) infection, a life-threatening condition with significant unmet medical needs. Eiger's pipeline also includes Lambda, which is being evaluated in Phase 2 trials for HDV treatment, and Lonafarnib is being explored for its potential use in treating progeria and progeroid laminopathies. Additionally, Avexitide, which has completed Phase 2 trials for post-bariatric hypoglycemia, is also undergoing clinical evaluation for congenital hyperinsulinism. Eiger's strategic focus is on efficient drug development to deliver safe and effective therapies to patients suffering from these serious conditions.
Potenza Therapeutics
Venture Round in 2016
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company based in Cambridge, Massachusetts, established in 2014. The company is dedicated to developing a portfolio of oncology programs that harness the body's immune system to identify and eliminate tumors. Potenza's innovative approach focuses on understanding the mechanisms that allow cancer cells to evade immune detection and destruction. By leveraging these biological insights, the company aims to create effective and reliable therapeutic solutions that enhance patient health and improve cancer treatment outcomes.
Bigstep
Seed Round in 2016
Bigstep is a cloud provider established in 2013 and headquartered in London, with infrastructure located in the U.K. and Germany. Founded by Lucas Roh, the company specializes in offering professional analytics solutions through its Full Metal Cloud, specifically designed for big data environments. Bigstep's platform focuses on delivering high performance and low latency, providing businesses of all sizes with scalable storage, high-speed networking, and hardware upgrades. By leveraging advanced technologies and automation, Bigstep enables clients to optimize their operations for both cost and performance efficiency, making it easier for them to implement production-ready big data solutions quickly and effectively.
Tesaro, Inc. is an oncology-focused biopharmaceutical company established in 2010 and headquartered in Waltham, Massachusetts. The company is dedicated to developing and commercializing cancer therapeutics and supportive care products. Its primary offerings include ZEJULA, a potent oral poly polymerase inhibitor for the maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer, and VARUBI, a neurokinin-1 receptor antagonist designed to prevent chemotherapy-induced nausea and vomiting. Additionally, Tesaro is engaged in the development of several immunotherapy antibody candidates, including TSR-042, TSR-022, and TSR-033, all currently in phase I clinical trials. The company collaborates with various organizations, such as AnaptysBio, Janssen Biotech, and Merck Sharp & Dohme, to enhance its research and development efforts. Tesaro aims to leverage its management team's expertise to identify and commercialize innovative treatments that improve the lives of cancer patients. As of January 2019, Tesaro operates as a subsidiary of GlaxoSmithKline.
Tizona Therapeutics
Series B in 2016
Founded in 2014, Tizona Therapeutics is a biopharmaceutical company based in South San Francisco, California. It specializes in developing immunotherapies for cancer and autoimmune diseases, with a focus on understanding the role of regulatory T cells in various tumors.
Aria Systems
Series E in 2016
Aria Systems provides a cloud-based platform for managing recurring revenues. It offers Aria, an enterprise-grade solution for subscription-based billing, serving clients across hi-tech, media, telecom, and finance industries worldwide.
Stellar Loyalty
Series A in 2016
Stellar Loyalty Inc. is a provider of cloud-based customer loyalty and engagement solutions founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines. The company specializes in mobile and big data solutions that enable brands to connect their loyalty programs with point-of-sale, marketing, and customer relationship management systems. This integration allows businesses to recognize, engage, and reward their customers effectively. Stellar Loyalty's platform offers functionalities in calculations, business rules, segmentations, and predictive analytics, aimed at enhancing consumer experiences across various interaction channels, including digital, physical, and human touchpoints.
Tizona Therapeutics
Series A in 2016
Founded in 2014, Tizona Therapeutics is a biopharmaceutical company based in South San Francisco, California. It specializes in developing immunotherapies for cancer and autoimmune diseases, with a focus on understanding the role of regulatory T cells in various tumors.
Benvenue Medical
Series F in 2016
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. Its product offerings include the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer â C system, designed for treating pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system suitable for various surgical approaches. The company serves a diverse customer base across the United States, Canada, Belgium, France, and Germany. Founded in 2004, Benvenue Medical is headquartered in Santa Clara, California, and is focused on developing innovative surgical solutions that enhance patient outcomes and restore spinal alignment.
Crowdpac, Inc. is a non-partisan political technology company founded in 2013 and headquartered in San Francisco, California. The company provides an online platform designed to enhance political participation by offering a comprehensive and accessible source of information about candidates and political issues. Crowdpac compiles crucial data on candidates, including funding sources, positions on key issues, voting behavior, and past political activities, enabling users to make informed decisions aligned with their values. The platform allows individuals to browse candidates based on various issues, such as healthcare, education, and environmental policy, fostering a representative democracy. Additionally, Crowdpac offers crowdfunding tools that empower candidates, organizations, and citizens to finance political change and support candidates independent of major donors and special interests. As a subsidiary of Prytany, Crowdpac aims to increase civic engagement and facilitate the political process for all citizens.
Triposo
Venture Round in 2015
Triposo, Inc. specializes in developing interactive travel guides for mobile devices, offering users country maps, city guides, and a wealth of information about local culture, history, and activities. Founded in 2010 and based in Amersfoort, the Netherlands, Triposo uses an algorithmic approach to curate relevant travel options in real-time for various destinations. The company has released around 20 iOS guides and 50 Android guides, utilizing open content from reputable sources such as Wikitravel, Wikipedia, and OpenStreetMap. This mobile application enables users to access offline maps and detailed information about restaurants, bars, nightlife, and recreational activities, enhancing their travel planning experience. As of 2017, Triposo operates as a subsidiary of Musement S.r.l.
Celladon Corporation, established in 2000 and headquartered in La Jolla, California, is a biotechnology company focused on developing molecular therapies for treating heart failure. The company's primary product candidate is MYDICAR, an enzyme replacement therapy aimed at addressing the key enzyme deficiency in advanced heart failure. This therapy targets SERCA2a, an enzyme crucial for regulating calcium cycling and contractility in heart muscle cells.
Avedro, Inc. is a commercial-stage ophthalmic pharmaceutical and medical device company headquartered in Waltham, Massachusetts. The company specializes in developing and commercializing innovative products for treating corneal disorders, primarily focusing on corneal ectatic conditions and refractive issues. Avedro's proprietary Corneal Remodeling Platform includes the KXL and Mosaic systems, which utilize ultraviolet A (UVA) light in conjunction with riboflavin drug formulations for corneal cross-linking. This technology is aimed at strengthening and reshaping the cornea through minimally invasive and non-invasive outpatient procedures. Avedro has also introduced the Keraflex refractive correction procedure, a non-invasive technique for flattening the cornea without tissue removal. While Avedro primarily serves ophthalmologists, hospitals, and ambulatory surgery centers in the United States, it also markets its products internationally through medical device distributors. The company, originally named ThermalVision, Inc., was incorporated in 2002 and rebranded as Avedro in 2005. As of November 2019, Avedro operates as a subsidiary of Glaukos Corporation.
Polymorph
Series A in 2015
Polymorph is a technology company based in San Francisco, California, specializing in monetization infrastructure for modern enterprises. Founded in 2013, Polymorph offers a white-label software-as-a-service platform designed for publishers to optimize revenue while enhancing user experiences. The platform provides a comprehensive ad serving stack, yield optimization tools, and APIs, enabling flexible access to demand through both server-side and self-serve workflows. By facilitating the integration of visually appealing advertisements that blend seamlessly with content, Polymorph empowers publishers and media companies to effectively manage non-standard advertising placements across digital channels. The company's customizable and developer-friendly solutions cater to the specific needs of enterprises looking to monetize their digital assets through advertising.
Welcome is a marketing orchestration platform, designed to streamline and optimize marketing operations for large, ambitious brands. It aligns marketing teams, simplifies campaign execution, and provides measurable results. Welcome integrates with other marketing technology tools, enabling better collaboration and performance tracking. It serves as a central hub for marketing teams, supporting their growth and enhancing overall marketing performance.
Mobee is a mobile crowd-sourcing platform that leverages mobile technology to gather offline data and insights about shopper experiences. Through its app, Mobee rewards users for providing feedback on their shopping encounters, thereby facilitating a more engaging and interactive way for businesses to collect valuable data. The platform enables retailers and brand manufacturers to analyze this information in real-time, offering persona-based alerts and integrating seamlessly with existing workflows. This approach allows companies to conduct comprehensive reviews of the shopper experience more efficiently and cost-effectively than traditional mystery shopping or merchandising services, ultimately aiding them in making informed business decisions.
Wiser Solutions
Series A in 2015
Wiser Solutions is a leading provider of actionable data aimed at enhancing decision-making for brands and retailers. The company specializes in collecting and analyzing both online and in-store data with notable speed and precision. Its platform integrates insights from the retail sector with advanced workflow software, creating a comprehensive solution that serves various retail needs, including those of restaurants. By combining data science with human validation, Wiser offers a centralized approach to retail data analysis, enabling businesses to drive revenue, reduce costs, and improve marketing efficiency.
Gynesonics
Venture Round in 2015
Gynesonics, Inc. is a medical device company focused on developing innovative solutions for women's health, specifically addressing symptomatic uterine fibroids. Founded in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, Gynesonics offers the Sonata System, a minimally invasive treatment that utilizes sonography guidance for the transcervical ablation of fibroids. This incision-free approach provides a safe and effective alternative to traditional surgical methods such as hysterectomy or myomectomy, aiming to alleviate severe menstrual symptoms associated with fibroids. Gynesonics is dedicated to improving the quality of care for women by offering advanced technologies that enhance treatment options in gynecology.
Autonomic Technologies, Inc. is a medical device company that specializes in developing and commercializing innovative therapies for autonomic disorders, with a particular emphasis on severe headaches. Founded in 2007 and headquartered in Mountain View, California, the company has additional offices in Germany and Switzerland. Its flagship product, the ATI Neurostimulation System, is a miniaturized, battery-less microstimulator designed to deliver low-level energy directly to the sphenopalatine ganglion (SPG) to effectively treat chronic cluster headaches. This technology aims to set a new standard in the management of severe headaches and migraines, providing patients with a safe and effective treatment option.
Joyus is a startup that offers an innovative online shopping experience centered around short-form videos. The company focuses on helping users discover and purchase products, primarily in the apparel, beauty, and lifestyle sectors, through engaging video content. Each week, Joyus features curated selections of items, showcasing how to utilize them effectively. This exclusive video sales platform allows customers to buy products for a limited time, making the shopping experience both dynamic and accessible. Joyus also emphasizes community engagement, enabling users to share their favorite videos easily on social media. By combining editorial content with direct-response video, the company provides a unique way for consumers to stay informed about the latest trends and gain expert advice, ultimately transforming the traditional shopping experience.
Autonomic Technologies, Inc. is a medical device company that specializes in developing and commercializing innovative therapies for autonomic disorders, with a particular emphasis on severe headaches. Founded in 2007 and headquartered in Mountain View, California, the company has additional offices in Germany and Switzerland. Its flagship product, the ATI Neurostimulation System, is a miniaturized, battery-less microstimulator designed to deliver low-level energy directly to the sphenopalatine ganglion (SPG) to effectively treat chronic cluster headaches. This technology aims to set a new standard in the management of severe headaches and migraines, providing patients with a safe and effective treatment option.
The RealReal
Series D in 2015
The RealReal operates an online marketplace for authenticated luxury resale, offering fashion for women, men and kids, as well as jewelry, watches, art and home items. Founded in 2011 and headquartered in San Francisco, it functions as a full-service consignment platform that authenticates every item through in-house experts and uses technology to determine pricing, while managing photography, listings, payments and shipping. It is the largest pure-play luxury resale platform in the United States and supports a sustainable circular economy by facilitating resale across multiple categories. The company generates revenue primarily from consignments and first-party sales on its marketplace, with additional direct sales, and provides services such as virtual appointments, in-home pickup and direct shipping to buyers.
Aryaka Networks
Series C in 2015
Aryaka Networks designs and delivers cloud-based network connectivity and application acceleration solutions for enterprises worldwide. Its unified Secure Access Service Edge (SASE) platform combines networking and security functions, optimizing global Wide Area Network performance and enhancing security in over 100 countries.
Pivot3 specializes in hyperconverged infrastructure and flash storage solutions. Founded with a vision to simplify data centers, Pivot3 unifies storage, compute, and network resources into easy-to-deploy systems that reduce costs, risks, and complexity. Today, they offer Dynamic Hyperconverged and PCIe Flash Arrays, ensuring high availability and optimal performance for mission-critical applications. With over 16,000 deployments across various industries worldwide, Pivot3 helps businesses lower total cost of ownership, ensure uninterrupted revenue generation, improve customer satisfaction, and maximize employee productivity.
Invuity
Private Equity Round in 2015
Invuity is a medical technology company that develops visualization products for minimally invasive and open surgeries. Using photonics technology, it directs and shapes light to provide broad, uniform illumination and direct visualization inside dark surgical cavities, enabling enhanced precision, efficiency, and safety. The product line includes illuminated retractors and handheld and intracavity illumination systems used in breast, orthopedic, spine, neurosurgery, endocrine, gynecologic, colorectal, and general procedures. Examples include Eikon LT and Eiberg illuminated retractors, PhotonBlade and PhotonSaber handheld illuminators, Breiten retractors, Photonguide XT intracavity illuminator, and PhotonVue visualization with indocyanine green imaging. Devices come in single-use and reusable formats and are sold directly to hospitals, surgeons, and to third-party manufacturers. Founded in 2004 and based in San Francisco, Invuity originated as Spotlight Surgical.
Obalon Therapeutics
Series D in 2015
Obalon Therapeutics, Inc. is a medical device company based in Carlsbad, California, that specializes in developing and commercializing innovative solutions for obesity treatment. The company's flagship product, the Obalon Balloon System, is designed to assist weight loss in obese patients through a swallowable capsule that contains an inflatable balloon. This system includes the Obalon Navigation System, which utilizes hardware and software to monitor the balloon's placement, as well as the Obalon Touch Inflation Dispenser, a semi-automated device for inflating the balloon post-placement. Founded in 2008, Obalon emphasizes engineering excellence and close collaboration with clinicians to create high-quality medical products aimed at improving patient outcomes. As of early 2020, the company operated three retail treatment centers in California, underscoring its commitment to providing accessible weight loss solutions.
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltokâs solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.
Sera Prognostics
Series B in 2015
Sera Prognostics, Inc. is a biotechnology company that develops diagnostic tests to predict a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other pregnancy complications. Using proteomics and bioinformatics, it discovers and commercializes blood-based biomarker tests and predictive analytics to guide early, personalized interventions and reduce healthcare costs associated with pregnancy complications. Founded in 2008 and based in Salt Lake City, Utah, Sera aims to improve maternal and neonatal outcomes by providing physicians with actionable risk information during pregnancy.
Knotch
Venture Round in 2015
Knotch, Inc. is an independent provider of real-time intelligence focused on enhancing digital marketing efforts. Established in 2012 and based in San Francisco, the company offers the Knotch intelligence suite, which equips brands and marketers with tools to gain real-time insights, metrics, and benchmarks. Knotch addresses a critical challenge faced by both B2B and B2C marketers by bridging the "missing middle" of the audience journey, thereby reducing guesswork and improving efficiency. The platform allows marketers to track the impact of content assets through all stages of the audience journey, identifying which content drives high-value actions and conversions. Additionally, Knotch's digital content intelligence platform facilitates content research, data collection, analysis, and optimization, enabling marketing and media teams to effectively plan and enhance their content strategies across various advertising channels.
Cuyana
Venture Round in 2015
Cuyana, Inc. is a San Francisco-based fashion brand that focuses on manufacturing and retailing high-quality clothing, bodysuits, bags, small leather goods, and accessories. Founded in 2011, the company promotes the philosophy of "fewer, better things," offering timeless pieces designed with a modern aesthetic and crafted from premium materials to ensure durability. Cuyana operates an online platform for direct-to-consumer sales, allowing it to provide luxury-quality products at attainable prices. In addition to its online presence, Cuyana has physical showrooms in locations such as Palo Alto, New York City, Pacific Palisades, and Venice. Through its unique approach, Cuyana aims to bridge the gap between luxury and affordability in the fashion industry.
InVisage Technologies
Series F in 2014
InVisage Technologies, Inc. is a fabless semiconductor company headquartered in Menlo Park, California, that specializes in the development of QuantumFilm-based image sensors. Founded in 2005, the company produces advanced imaging technology designed to capture high-fidelity and high-resolution images from mobile devices, including camera phones and digital cameras. InVisage's innovative sensors are capable of absorbing a full spectrum of light, resulting in superior image quality. Their products are utilized across various applications, such as security and surveillance, automotive imaging, military, and medical imaging. InVisage Technologies operates as a subsidiary of Apple Inc. as of November 2017, further enhancing its position in the imaging technology market.
PMV Pharmaceuticals
Series A in 2014
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.
Restoration Robotics
Series C in 2014
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. It has developed the ARTAS⢠System, an innovative image-guided platform that facilitates follicular unit extraction, enhancing the precision and efficiency of hair restoration procedures. By integrating advanced imaging and robotics, Restoration Robotics aims to improve outcomes for patients seeking hair transplants, positioning itself as a leader in the evolving field of hair restoration. The company is committed to transforming traditional practices through its state-of-the-art technology.
Pivot3 specializes in hyperconverged infrastructure and flash storage solutions. Founded with a vision to simplify data centers, Pivot3 unifies storage, compute, and network resources into easy-to-deploy systems that reduce costs, risks, and complexity. Today, they offer Dynamic Hyperconverged and PCIe Flash Arrays, ensuring high availability and optimal performance for mission-critical applications. With over 16,000 deployments across various industries worldwide, Pivot3 helps businesses lower total cost of ownership, ensure uninterrupted revenue generation, improve customer satisfaction, and maximize employee productivity.
Stellar Loyalty
Series A in 2014
Stellar Loyalty Inc. is a provider of cloud-based customer loyalty and engagement solutions founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines. The company specializes in mobile and big data solutions that enable brands to connect their loyalty programs with point-of-sale, marketing, and customer relationship management systems. This integration allows businesses to recognize, engage, and reward their customers effectively. Stellar Loyalty's platform offers functionalities in calculations, business rules, segmentations, and predictive analytics, aimed at enhancing consumer experiences across various interaction channels, including digital, physical, and human touchpoints.
Braze is a customer engagement platform that helps brands deliver relevant, human experiences across channels. It offers a mobile marketing automation and customer relationship management solution with AI-powered tools for engagement orchestration, including messaging, chatbots, and content management, plus campaign optimization insights, data analysis, and segment analytics. The platform enables cross-channel personalization across mobile, email, web, television, and connected devices, and provides data security, data warehousing and streaming capabilities. Braze uses AI to power functionality across its stack. Founded in 2011 and headquartered in New York, it has offices in London, San Francisco, Chicago, and Singapore. Braze serves industries such as retail and e-commerce, media and entertainment, financial services, and travel and hospitality, focusing on timely, contextually relevant interactions between consumers and brands.
Opal Labs Inc. is a marketing collaboration platform based in Portland, Oregon, founded in 2009. The company provides an online platform that enables organizations to effectively plan, create, view, edit, and approve their brand marketing content. By promoting alignment among marketing teams, Opal facilitates strategic campaign creation, streamlines the review process, and enhances content management, thereby reducing complexity and breaking down silos within organizations. The platform integrates seamlessly with various distribution methods, allowing teams to work together more efficiently and achieve successful marketing outcomes.
Pivot3 specializes in hyperconverged infrastructure and flash storage solutions. Founded with a vision to simplify data centers, Pivot3 unifies storage, compute, and network resources into easy-to-deploy systems that reduce costs, risks, and complexity. Today, they offer Dynamic Hyperconverged and PCIe Flash Arrays, ensuring high availability and optimal performance for mission-critical applications. With over 16,000 deployments across various industries worldwide, Pivot3 helps businesses lower total cost of ownership, ensure uninterrupted revenue generation, improve customer satisfaction, and maximize employee productivity.
Splice Machine
Series B in 2014
Splice Machine is a data platform company offering a hybrid, open-source dual-engine relational database and a unified data layer that combines streaming, analytics and transactions. The platform supports mixed operational and analytical workloads, running operational tasks on one engine with Hadoop and HBase and analytical tasks on Spark, enabling real-time updates for applications and batch analysis for insights. It helps replace traditional databases by reducing latency and cost and supports the development of real-time, scalable applications. With built-in machine learning support, the platform accelerates offloading workloads and integrates analytics and AI into mission-critical applications across IoT, ETL, operational reporting and other data-driven workflows. The company is based in San Francisco.
Gynesonics
Debt Financing in 2014
Gynesonics, Inc. is a medical device company focused on developing innovative solutions for women's health, specifically addressing symptomatic uterine fibroids. Founded in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, Gynesonics offers the Sonata System, a minimally invasive treatment that utilizes sonography guidance for the transcervical ablation of fibroids. This incision-free approach provides a safe and effective alternative to traditional surgical methods such as hysterectomy or myomectomy, aiming to alleviate severe menstrual symptoms associated with fibroids. Gynesonics is dedicated to improving the quality of care for women by offering advanced technologies that enhance treatment options in gynecology.
Cidara Therapeutics
Series A in 2014
Cidara Therapeutics is a biotechnology company dedicated to developing novel anti-infectives. Its primary focus is rezafungin acetate, an antifungal for treating serious invasive fungal infections. Additionally, it advances the Cloudbreak platform to develop antiviral therapies using Fc-conjugates.
Benvenue Medical
Series E in 2014
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. Its product offerings include the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer â C system, designed for treating pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system suitable for various surgical approaches. The company serves a diverse customer base across the United States, Canada, Belgium, France, and Germany. Founded in 2004, Benvenue Medical is headquartered in Santa Clara, California, and is focused on developing innovative surgical solutions that enhance patient outcomes and restore spinal alignment.
Victorious
Series A in 2014
Victorious is a Santa Monica-based company founded in 2013 that specializes in search engine optimization (SEO) as a primary marketing strategy. By focusing exclusively on SEO, Victorious aims to transform it into a key channel for lead generation rather than a supportive tactic for other marketing efforts. The company offers a comprehensive suite of SEO services designed to enhance online visibility and deliver measurable business outcomes. Victorious is committed to generating long-term return on investment for its clients, aligning their strategies with broader marketing goals and fostering sustainable business growth. Through its innovative approach, Victorious is redefining the significance of SEO in driving success for businesses.
Aryaka Networks
Series C in 2014
Aryaka Networks designs and delivers cloud-based network connectivity and application acceleration solutions for enterprises worldwide. Its unified Secure Access Service Edge (SASE) platform combines networking and security functions, optimizing global Wide Area Network performance and enhancing security in over 100 countries.
Apteligent
Series C in 2014
Apteligent, Inc. is a provider of mobile application intelligence solutions, headquartered in San Francisco, California. Founded in 2010, the company specializes in application performance management, offering a suite of tools that enable enterprises to enhance their mobile business by delivering critical insights throughout the application lifecycle. Its key offerings include Userflows, which connects user experiences with business metrics; a Crash Reporting solution that identifies and monitors application errors; and Service Monitoring, which analyzes service and API performance. Apteligent supports various mobile operating systems, including iOS, Android, and Windows Phone, and serves a diverse range of industries such as finance, retail, gaming, and hospitality. The company was previously known as Crittercism, Inc. and rebranded to Apteligent in February 2016. As of 2017, Apteligent operates as a subsidiary of VMware, Inc.
The RealReal
Series C in 2014
The RealReal operates an online marketplace for authenticated luxury resale, offering fashion for women, men and kids, as well as jewelry, watches, art and home items. Founded in 2011 and headquartered in San Francisco, it functions as a full-service consignment platform that authenticates every item through in-house experts and uses technology to determine pricing, while managing photography, listings, payments and shipping. It is the largest pure-play luxury resale platform in the United States and supports a sustainable circular economy by facilitating resale across multiple categories. The company generates revenue primarily from consignments and first-party sales on its marketplace, with additional direct sales, and provides services such as virtual appointments, in-home pickup and direct shipping to buyers.
Doximity is a cloudâbased digital platform that serves U.S. medical professionals. It offers a professional network and a suite of tools designed for collaboration, secure patient care coordination, virtual visits, career management, and access to the latest medical news and research. The platform is used by more than 70% of U.S. physicians across all specialties and practice areas.
Integrated Diagnostics
Series B in 2014
Integrated Diagnostics Inc. is a company focused on developing laboratory-based blood diagnostic tools that facilitate the early diagnosis of complex diseases through non-invasive blood tests. Established in 2005 and headquartered in Seattle, Washington, the company specializes in products that monitor multiple molecular markers simultaneously, offering valuable insights for conditions such as lung cancer. One of its key offerings is Xpresys Lung, a molecular blood test designed to provide objective information for assessing pulmonary nodules. Integrated Diagnostics is committed to leveraging advanced technologies to create a pipeline of innovative diagnostic products aimed at enhancing disease management for conditions including cancer, diabetes, and Alzheimer's. The company operates under a strategic partnership with Agilent Technologies Inc. and has been functioning as a subsidiary of Biodesix, Inc. since 2018.
Damballa is a company specializing in advanced threat protection, focusing on the identification and mitigation of active security threats that bypass traditional prevention methods. Utilizing patent-pending solutions that integrate data science and machine learning, Damballa automatically detects infections and highlights devices posing the highest risk to enterprises. Its technology is designed to discover threats without prior knowledge of them and is applicable across various device types and operating systems. The company protects nearly a billion endpoints worldwide, serving clients in every major market, including large internet service providers and telecommunications companies. Damballa's software also addresses issues related to botnet formation, helping organizations combat the unauthorized transmission of spam and viruses over the Internet.
InVisage Technologies
Series E in 2014
InVisage Technologies, Inc. is a fabless semiconductor company headquartered in Menlo Park, California, that specializes in the development of QuantumFilm-based image sensors. Founded in 2005, the company produces advanced imaging technology designed to capture high-fidelity and high-resolution images from mobile devices, including camera phones and digital cameras. InVisage's innovative sensors are capable of absorbing a full spectrum of light, resulting in superior image quality. Their products are utilized across various applications, such as security and surveillance, automotive imaging, military, and medical imaging. InVisage Technologies operates as a subsidiary of Apple Inc. as of November 2017, further enhancing its position in the imaging technology market.
Polymorph
Seed Round in 2014
Polymorph is a technology company based in San Francisco, California, specializing in monetization infrastructure for modern enterprises. Founded in 2013, Polymorph offers a white-label software-as-a-service platform designed for publishers to optimize revenue while enhancing user experiences. The platform provides a comprehensive ad serving stack, yield optimization tools, and APIs, enabling flexible access to demand through both server-side and self-serve workflows. By facilitating the integration of visually appealing advertisements that blend seamlessly with content, Polymorph empowers publishers and media companies to effectively manage non-standard advertising placements across digital channels. The company's customizable and developer-friendly solutions cater to the specific needs of enterprises looking to monetize their digital assets through advertising.
DataRPM Corporation is a provider of a cognitive data science platform that automates machine learning for enterprises, available both on-cloud and on-premises. Founded in 2011 and headquartered in Redwood City, California, with additional offices in the United States, the United Kingdom, and Bengaluru, India, DataRPM specializes in predictive analytics, particularly in the areas of predictive maintenance for the industrial Internet of Things. Its platform connects to data lakes and conducts various machine learning experiments, identifying patterns, anomalies, and influencing factors to create predictive models. This enables organizations to enhance operational efficiency, reduce maintenance costs, and optimize resources. Catering primarily to Fortune 500 companies, DataRPM aims to empower users as citizen data scientists through an intuitive natural language interface, facilitating digital transformation across diverse sectors. As of 2017, DataRPM operates as a subsidiary of Progress Software Corporation.
Grokker operates an online fitness platform offering thousands of expert-led videos covering various cooking styles, yoga practices, and workout routines. Its holistic wellness program caters to employees worldwide, promoting physical health through personalized video content and community support.
Invuity is a medical technology company that develops visualization products for minimally invasive and open surgeries. Using photonics technology, it directs and shapes light to provide broad, uniform illumination and direct visualization inside dark surgical cavities, enabling enhanced precision, efficiency, and safety. The product line includes illuminated retractors and handheld and intracavity illumination systems used in breast, orthopedic, spine, neurosurgery, endocrine, gynecologic, colorectal, and general procedures. Examples include Eikon LT and Eiberg illuminated retractors, PhotonBlade and PhotonSaber handheld illuminators, Breiten retractors, Photonguide XT intracavity illuminator, and PhotonVue visualization with indocyanine green imaging. Devices come in single-use and reusable formats and are sold directly to hospitals, surgeons, and to third-party manufacturers. Founded in 2004 and based in San Francisco, Invuity originated as Spotlight Surgical.
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltokâs solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.
Totango develops a customer success platform that helps businesses drive customer adoption, retention, expansion, and referrals. Its solutions include automated workflows, engagement features, and AI-powered predictive analytics to monitor customer health and proactively reduce churn. Totango serves leading customer success teams worldwide, including SAP and GitHub.
Welcome is a marketing orchestration platform, designed to streamline and optimize marketing operations for large, ambitious brands. It aligns marketing teams, simplifies campaign execution, and provides measurable results. Welcome integrates with other marketing technology tools, enabling better collaboration and performance tracking. It serves as a central hub for marketing teams, supporting their growth and enhancing overall marketing performance.
Crowdpac
Seed Round in 2014
Crowdpac, Inc. is a non-partisan political technology company founded in 2013 and headquartered in San Francisco, California. The company provides an online platform designed to enhance political participation by offering a comprehensive and accessible source of information about candidates and political issues. Crowdpac compiles crucial data on candidates, including funding sources, positions on key issues, voting behavior, and past political activities, enabling users to make informed decisions aligned with their values. The platform allows individuals to browse candidates based on various issues, such as healthcare, education, and environmental policy, fostering a representative democracy. Additionally, Crowdpac offers crowdfunding tools that empower candidates, organizations, and citizens to finance political change and support candidates independent of major donors and special interests. As a subsidiary of Prytany, Crowdpac aims to increase civic engagement and facilitate the political process for all citizens.
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.
Flurry, Inc. is a mobile application analytics and advertising platform that assists businesses in understanding and monetizing user interactions with their mobile applications. Founded in 2005 and headquartered in San Francisco, Flurry offers a comprehensive suite of products, including Flurry Analytics, which tracks consumer behavior across over 400,000 applications, providing insights into audience engagement and retention. The platform also features AppSpot for ad serving, AppCircle for audience building, Flurry Personas for targeted marketing, and Flurry Marketplace for streamlined access to advertisers. With more than 125,000 companies utilizing its services, Flurry handles over 1 billion end-user sessions monthly across various devices, including iOS, Android, and Windows Phone. Flurry is a subsidiary of Yahoo! Inc. as of 2014.
Aria Systems
Series D in 2013
Aria Systems provides a cloud-based platform for managing recurring revenues. It offers Aria, an enterprise-grade solution for subscription-based billing, serving clients across hi-tech, media, telecom, and finance industries worldwide.